antiendotheli
cell
antibodi
aeca
repres
heterogen
famili
autoantibodi
direct
structur
endotheli
protein
well
antigen
adher
endotheli
cell
although
aeca
immunoassay
still
show
highinterlaboratori
variabl
sever
find
suggest
pathogen
role
autoantibodi
diseas
character
endotheli
damag
chapter
analyz
knowledg
aeca
preval
clinic
relev
pathogen
role
autoimmun
diseas
focus
particular
system
lupu
erythematosu
antiphospholipid
syndrom
system
sclerosi
ssc
system
vascul
increas
bodi
evid
last
two
decad
report
presenc
autoantibodi
direct
heterogen
famili
structur
endotheli
protein
well
antigen
adher
endotheli
cell
ec
patient
diseas
character
endotheli
damag
fig
vascular
ec
play
import
role
mani
process
blood
pressur
regul
coagul
fibrinolysi
angiogenesi
blood
cell
activ
physiolog
patholog
process
far
antiendotheli
cell
antibodi
aeca
correl
diseas
activ
vascular
involv
sever
diseas
much
evort
made
determin
whether
aeca
mediatedmechan
underli
develop
diseas
mere
repres
marker
vascular
damag
intriguingli
endotheli
antigen
readili
access
circul
antibodi
pathogen
role
aeca
suggest
sever
author
particular
recent
find
suggest
aeca
may
activ
ec
upregul
cell
adhes
molecul
cam
induc
secret
proinflammatori
cytokin
suggest
aeca
might
also
activ
ec
interact
tolllik
receptor
molecular
mimicri
gpi
microbi
structur
repres
natur
ligand
final
controversi
result
report
regard
induct
ec
apoptosi
aeca
although
well
known
autoantibodi
bind
apoptot
ec
thu
increas
phagocytosi
macrophag
clearanc
apoptot
cell
chapter
analyz
knowledg
aeca
autoimmun
diseas
focus
particular
pathogen
role
system
lupu
erythematosu
sle
antiphospholipid
syndrom
ap
system
sclerosi
ssc
vascul
sinc
discoveri
aeca
sever
studi
focus
role
diagnost
tool
diseas
character
inflamm
blood
vessel
despit
grow
interest
field
aeca
immunoassay
still
show
highinterlaboratori
variabl
probabl
due
lack
intern
standard
mani
method
develop
detect
aeca
includ
immunofluoresc
immunoassay
elisa
ria
use
fix
cell
western
blot
wb
fluorescenceactiv
cell
sorter
analysi
fac
nevertheless
small
number
compar
studi
done
data
concern
sensit
specif
method
detect
aeca
frequent
variabl
inconclus
review
ref
major
part
knowledg
aeca
reactiv
come
vitro
experi
human
umbil
vein
ec
huvec
nevertheless
isol
primari
huvec
labori
aeca
reactiv
obtain
diver
donor
easili
compar
diver
origin
moreov
huvec
present
short
life
span
kept
cultur
short
period
anoth
point
debat
fixat
procedur
huvec
may
influenc
aeca
reactiv
intracytoplasm
membran
antigen
interfer
heterophil
antibodi
recogn
fetal
calf
serum
fc
protein
may
avoid
ad
fc
dilut
buver
final
diver
ec
macroand
microvasculatur
use
aeca
detect
diver
result
ec
divers
tissu
also
heterogen
respect
small
vs
larg
vessel
also
respect
surfac
phenotyp
protein
express
instanc
renaudineau
et
al
show
highest
preval
aeca
reactiv
larg
seri
patient
ssc
use
microvascular
bone
marrow
ec
comparison
huvec
need
reproduc
result
increas
demand
immort
ec
line
gener
fusion
huvec
human
lung
carcinoma
cell
line
immort
human
microvascular
ec
line
ec
deriv
human
umbil
iliac
vein
arteri
transfect
plasmid
contain
simian
viru
larg
tantigen
may
also
use
detect
aeca
immort
human
glomerular
endotheli
cell
hgec
line
also
gener
cell
line
maintain
morpholog
function
characterist
hgec
even
sever
week
cultur
thu
provid
standard
substrat
aeca
detect
nevertheless
aeca
detect
immort
ec
may
subject
great
variabl
scientist
interest
autoimmun
ec
would
prefer
primari
ec
line
substrat
cell
probabl
present
primari
endotheli
trait
although
origin
cytoelisa
remain
wide
use
method
detect
aeca
advis
confirm
posit
result
use
method
flow
cytometri
immunoprecipit
wb
appear
diycult
use
routin
basi
import
point
heat
sera
avoid
treatment
increas
aeca
bind
nonspecif
mechan
sera
patient
healthi
individu
ana
rf
serum
sampl
shown
interfer
aeca
detect
elisa
nucleusdeplet
lysat
prepar
final
report
diver
aeca
isotyp
may
preval
diver
autoimmun
disord
discuss
elsewher
chapter
point
aeca
test
includ
determin
igg
igm
disord
addit
iga
patient
henochschonlein
purpura
hsp
fact
igg
aeca
predomin
autoimmun
condit
igm
aeca
shown
particularli
increas
kawasaki
diseas
kd
probabl
reflect
acut
natur
disord
addit
igg
igm
aeca
may
exert
divers
pathogen
role
due
diverenti
abil
fix
activ
complement
cascad
well
induc
ec
damag
via
antibodydepend
cytotox
antiphospholipid
syndrom
sle
protean
autoimmun
diseas
character
largest
number
detect
autoantibodi
reactiv
antigen
local
nucleu
cytoplasm
cell
membran
review
ref
antidsdna
antibodi
complement
consumpt
establish
marker
diseas
activ
larg
number
studi
focus
associ
autoantibodi
specif
symptom
sle
exampl
well
known
antidsdna
antibodi
well
antibodi
collagenlik
region
complement
compon
associ
renal
involv
sle
moreov
antiro
antibodi
found
marker
neonat
lupu
subacut
cutan
lupu
gpi
anticardiolipin
acl
antibodi
significantli
correl
clinic
thrombosi
abort
fetal
loss
despit
fact
studi
shown
higher
preval
aeca
sle
clinic
relev
autoantibodi
still
matter
debat
preval
aeca
sle
larg
rang
depend
method
patient
select
nonetheless
presenc
vascul
sle
frequent
associ
aeca
although
autoantibodi
correl
sever
clinic
manifest
diseas
lupu
nephriti
pleurisi
thrombocytopenia
neuropsychiatr
symptom
inflammatori
thrombot
vascular
injuri
repres
one
frequent
lesion
sle
endotheli
perturb
induc
aeca
may
involv
earliest
event
pathophysiolog
vascular
tissu
damag
vessel
size
may
avect
therefor
clinic
scenario
vascul
sle
extrem
wide
hashemi
cowork
describ
associ
aeca
vascul
thereaft
del
papa
et
al
show
sera
sle
patient
vascul
immunoprecipit
ec
surfac
protein
rang
kda
song
cowork
describ
higher
posit
rate
aeca
patient
digit
vascul
previous
report
studi
iggaeca
show
posit
correl
diseas
activ
sle
patient
moreov
signific
correl
iggaeca
titer
sle
diseas
activ
index
sledai
score
modif
also
observ
sle
patient
treatment
thu
aeca
may
use
followup
patient
solubl
marker
ec
dysfunct
von
willebrand
factor
thrombomodulin
solubl
eselectin
seem
surrog
marker
epiphenomenon
relat
ec
damag
possibl
aeca
may
repres
marker
cell
injuri
sign
polyclon
activ
humor
immun
respons
diseas
liver
transplant
aeca
correl
cytomegaloviru
cmv
infect
associ
higher
frequenc
humor
allograft
reject
aeca
found
patient
sle
urticari
vascul
uv
well
hypocomplementem
urticari
vascul
syndrom
huv
dcruz
colleagu
describ
high
preval
aeca
associ
reduc
serum
level
complement
sle
patient
uv
primari
uv
sle
patient
without
uv
bind
aeca
ec
may
accompani
format
immun
complex
complement
fixat
result
tissu
damag
antibodi
seem
specif
marker
huv
may
also
detect
occasion
sle
patient
without
uv
suggest
antibodi
could
contribut
ec
damag
crosslink
bound
immun
complex
surfac
ec
presenc
aeca
also
associ
thrombot
vascular
damag
patient
sle
well
primari
secondari
ap
regard
dieud
et
al
show
aeca
sle
patient
recogn
heatshock
protein
surfac
huvec
induc
apoptosi
relationship
high
titer
presenc
lupu
anticoagul
lac
thrombosi
sle
patient
also
observ
thu
author
suggest
pathophysiolog
pathway
thrombosi
induct
apoptosi
may
repres
initi
event
lead
apl
bind
anion
phospholipid
ec
surfac
may
initi
thrombot
cascad
antiendotheli
protein
c
receptor
epcr
autoantibodi
detect
ap
patient
repres
novel
risk
factor
fetal
death
higher
percentag
aeca
posit
also
observ
sneddon
syndrom
diseas
character
livedo
reticulari
ischem
cerebr
vascular
diseas
suggest
aeca
variou
isotyp
may
associ
lupu
nephriti
sle
particular
highest
aeca
level
detect
larg
seri
sle
patient
divus
prolif
glomerulonephr
time
renal
biopsi
proteinuria
nephrot
syndrom
aeca
show
highest
titer
activ
lupu
wherea
mean
antibodi
titer
fell
significantli
patient
enter
remiss
find
valid
prospect
studi
suggest
role
aeca
associ
laboratori
paramet
marker
diseas
activ
sle
autoantibodi
react
immunoblot
analysi
endotheli
cell
antigen
correl
presenc
glomerular
capillari
thrombi
heavi
proteinuria
anoth
studi
patient
lupu
nephriti
vascul
hypocomplementemia
show
iggaeca
membran
antigen
antibodi
ribosom
p
protein
identifi
molecular
clone
strategi
sle
patient
activ
diseas
nephriti
one
patient
autoantibodi
correl
total
aeca
level
well
antidna
antibodi
diseas
activ
renal
involv
longitudin
followup
nevertheless
date
posit
find
antidsdna
antibodi
higher
specif
activ
nephriti
sle
patient
apl
gpi
aeca
associ
variou
neurolog
manifest
patient
sle
vivo
observ
valid
mous
model
ap
develop
neurolog
dysfunct
hyperact
behavior
associ
apl
gpi
aeca
passiv
immun
human
acl
mab
demonstr
associ
presenc
aeca
psychiatr
manifest
psychosi
depress
sle
suggest
possibl
organ
mechan
underli
psychiatr
symptom
studi
signific
correl
found
acl
gpi
antiro
antigli
fibrillari
acid
protein
antiribosom
p
protein
antidsdna
antinucleosom
antibodi
psychiatr
involv
sle
patient
moreov
associ
found
aeca
reactiv
acl
gpi
antibodi
remark
screen
cdna
librari
human
umbil
arteri
ec
huaec
serum
sle
patient
acut
activ
psychosi
elev
aeca
serum
level
identifi
one
strongli
reactiv
clone
encod
ctermin
region
cter
intracytoplasm
protein
septin
famili
igg
specif
cter
present
sle
patient
elisa
mean
igg
reactiv
protein
significantli
higher
sle
patient
psychosi
mood
disord
contrari
correl
observ
presenc
cter
antibodi
clinic
featur
result
studi
suggest
relationship
aeca
antibodi
neuropsychiatr
involv
sle
support
hypothesi
biolog
origin
disturb
system
sclerosi
multisystem
disord
connect
tissu
character
immun
abnorm
microvascular
injuri
fibrot
chang
involv
skin
viscer
organ
lung
heart
gastrointestin
tract
kidney
well
recogn
vascular
injuri
appear
frequent
clinic
cours
diseasethat
raynaud
phenomenon
rp
vascular
dysfunct
repres
one
primari
event
pathogenesi
diseas
thu
surpris
signific
amount
research
clinic
basic
scientist
focus
identif
clinic
paramet
pathogen
mechan
endotheli
dysfunct
aeca
display
great
relev
field
investig
aeca
reactiv
scleroderma
quit
common
detect
overal
preval
vari
depend
method
use
elisa
wb
ig
isotyp
investig
substrat
tissu
section
sourc
human
ec
use
well
variabl
subtyp
ssc
patient
includ
limit
vs
divus
ssc
diver
studi
review
ref
consider
evort
focus
identif
associ
aeca
posit
clinic
manifest
ssc
earli
studi
involv
patient
divus
ssc
dssc
limit
ssc
lssc
primari
rp
prp
report
increas
preval
aeca
increas
sever
clinic
manifest
relat
ssc
analysi
limit
aeca
igg
author
observ
aeca
preval
patient
isol
rp
lssc
dssc
increas
preval
aeca
dssc
compar
lssc
also
report
negi
et
al
patient
ssc
preval
vs
although
result
suggest
import
role
aeca
identifi
diver
clinic
subset
ssc
confirm
later
studi
diver
aeca
reactiv
observ
patient
lssc
dssc
although
util
aeca
diverenti
main
clinic
subset
ssc
debat
signific
associ
aeca
reactiv
clinic
manifest
ssc
consist
report
aeca
found
close
associ
capillaroscopi
abnorm
well
sever
digit
ischemia
digit
ulcer
togeth
vascular
damag
strike
clinic
associ
aeca
observ
ssc
relat
lung
involv
particularli
import
sinc
lung
involv
manifest
either
interstiti
fibrosi
andor
pulmonari
hypertens
repres
frequent
caus
death
ssc
although
evalu
lung
involv
accord
diver
clinic
paramet
diagnost
procedur
least
four
report
demonstr
strict
associ
aeca
one
paramet
lung
diseas
ssc
salojin
et
al
demonstr
lung
involv
aeca
posit
patient
ssc
display
serum
aeca
reactiv
unfortun
character
lung
diseas
ie
isol
reduct
divus
capac
carbon
monoxid
dlco
pulmonari
fibrosi
pulmonari
hypertens
associ
aeca
avail
studi
negi
et
al
found
signific
correl
aeca
pulmonari
arteri
hypertens
pignon
et
al
report
strong
associ
reduc
dlco
pulmonari
arteri
hypertens
pulmonari
fibrosi
observ
particular
interest
consid
isol
dlco
reduct
indic
predictor
subsequ
develop
pulmonari
hypertens
final
ihn
et
al
observ
signific
associ
aeca
reduc
percent
vital
capac
vc
decreas
dlco
well
pulmonari
fibrosi
strongest
associ
sever
interstiti
lung
diseas
although
prospect
studi
yet
carri
avail
data
suggest
aeca
may
profound
clinic
relev
identifi
ssc
patient
major
risk
develop
advanc
vascular
damag
sever
pulmonari
diseas
manifest
either
interstiti
fibrosi
andor
pulmonari
hypertens
longitudin
studi
larg
number
patient
await
confirm
possibl
clinic
util
aeca
diseas
marker
ssc
put
antigen
respons
aeca
reactiv
sera
ssc
patient
identifi
sever
group
protein
band
variou
molecular
weight
obtain
wb
analysi
sera
react
cytoplasm
membran
protein
extract
huvec
ec
sourc
howev
absenc
molecular
biolog
approach
identifi
natur
antigen
observ
exact
endotheli
antigen
target
recogn
aeca
ssc
remain
elus
first
studi
report
identif
sever
membran
endotheli
cell
specif
antigen
diver
band
wb
analysi
target
aeca
ssc
patient
particular
reactiv
membran
antigen
kda
observ
patient
ssc
ssc
patient
crest
syndrom
shown
display
anticentromer
activ
ifi
analysi
although
interest
observ
confirm
subsequ
report
ihn
et
al
use
huvec
protein
extract
observ
reactiv
aeca
posit
sera
previous
assess
cytoelisa
huvec
toward
four
major
antigen
recogniz
wb
band
kda
common
respons
observ
antigen
purifi
kda
antibodi
display
cytoplasm
pattern
ifi
ident
observ
aeca
posit
sera
reactiv
observ
use
sera
toward
protein
extract
dermal
fibroblast
suggest
specif
immun
respons
endotheli
antigen
wusirika
et
al
report
reactiv
ssc
sera
pulmonari
involv
multipl
band
kda
obtain
wb
protein
extract
huvec
pulmonari
microvascular
ec
although
character
aeca
antigen
target
ssc
provid
report
clear
observ
autoimmun
condit
aeca
reactiv
ssc
rather
heterogen
identif
exact
antigen
respons
aeca
activ
ssc
sera
may
provid
import
clue
understand
pathogen
mechan
underli
endotheli
dysfunct
aggress
disord
detect
aeca
sera
patient
avect
system
vascul
rel
common
find
preval
vari
greatli
among
diver
form
vascul
earli
report
demonstr
abil
sera
children
acut
kd
lyse
huvec
pretreat
vitro
either
ifng
monokin
evect
observ
patient
acut
febril
kd
convalesc
phase
diseas
depend
presenc
circul
igm
aeca
activ
howev
later
studi
provid
conflict
evid
evect
role
aeca
kd
guzman
et
al
observ
aeca
patient
ks
aeca
abl
diverenti
kd
febril
disord
childhood
resembl
kd
similar
find
report
nash
et
al
children
acut
kd
show
increas
aeca
reactiv
compar
children
febril
infect
convers
kaneko
et
al
detect
igm
aeca
kd
children
half
display
complement
depend
cytotox
vitro
ec
final
falcini
et
al
report
aeca
reactiv
kd
patient
increas
incid
acut
compar
convalesc
phase
fujieda
et
al
observ
igm
aeca
igg
aeca
kd
children
confirm
increas
presenc
igm
aeca
reactiv
acut
phase
kd
although
evect
role
aeca
kd
still
matter
debat
suycient
evid
support
concept
igm
aeca
rise
subset
patient
acut
febril
phase
diseas
may
particip
endotheli
inflamm
lead
arter
kd
consist
evid
report
aeca
antineutrophil
cytoplasm
antibodi
anca
associ
system
vascul
ferraro
et
al
observ
aeca
mostli
igg
isotyp
sera
patient
microscop
polyangi
mpa
wegen
granulomatosi
wg
importantli
absorpt
anca
avect
endotheli
bind
aeca
suggest
aeca
anca
repres
two
diver
popul
autoantibodi
frampton
et
al
describ
increas
aeca
level
ancaassoci
vascul
signific
correl
two
antibodi
addit
aeca
anca
correl
diseas
activ
earlier
result
later
confirm
extens
evalu
aeca
reactiv
sera
patient
ancaposit
mpa
wg
aeca
present
patient
ancaassoci
vascul
igg
igm
interestingli
diver
kd
aeca
patient
abl
induc
complementdepend
cytotox
even
pretreat
ec
cytokin
minor
sera
induc
antibodydepend
cytotox
describ
elsewher
chapter
although
del
papa
et
al
observ
major
aecaposit
wg
patient
rel
conserv
precipit
pattern
wb
analysi
ec
surfac
extract
five
major
band
kda
find
await
confirm
larger
studi
thu
autoimmun
condit
natur
antigen
recogn
aeca
ancaassoci
vascul
current
unknown
two
studi
prospect
evalu
aeca
anca
level
patient
ancaassoci
vascul
assess
relationship
diseas
activ
report
demonstr
aeca
present
major
patient
observ
period
fluctuat
aeca
correl
diseas
activ
increas
titer
diseas
relaps
reduc
level
remiss
phase
although
encourag
result
provid
definit
evid
possibl
role
aeca
alon
associ
anca
predict
factor
clinic
relaps
ancaassoci
vascul
less
inform
avail
regard
role
aeca
form
system
vascul
takayasu
arter
ta
eichhorn
et
al
report
strike
incid
aeca
find
confirm
later
studi
report
incid
limit
evid
also
avail
churgstrauss
syndrom
css
schmitt
et
al
report
aeca
css
patient
contrast
anca
without
associ
diseas
activ
final
interest
find
report
regard
presenc
iga
aeca
patient
hsp
fujieda
et
al
observ
iga
aeca
nearli
hsp
patient
nephriti
interestingli
hsp
patient
without
nephriti
similar
result
obtain
yang
et
al
detect
aeca
iga
use
huvec
human
dermal
microvascular
endotheli
cell
hdmec
substrat
respect
huvec
aeca
iga
titer
correl
significantli
diseas
activ
summari
detect
aeca
sera
patient
avect
system
vascul
rel
common
find
preval
vari
greatli
among
diver
form
vascul
diver
observ
may
relat
preval
use
huvec
substrat
detect
aeca
despit
evid
diver
form
system
vascul
target
preferenti
vessel
diver
size
futur
evalu
aeca
use
substrat
ec
macroa
well
microvasculatur
may
import
assess
precis
aeca
reactiv
variou
form
vascul
addit
approach
may
also
provid
inform
preferenti
local
antigen
target
diver
form
vascul
allow
identif
new
antigen
specif
aeca
may
reveal
pathogen
import
regard
although
inconclus
preliminari
attempt
detect
aeca
use
ec
diver
sourc
variou
autoimmun
condit
suggest
may
repres
promis
experiment
approach
aeca
describ
number
system
autoimmuneinflammatori
diseas
alreadi
mention
instanc
increas
aeca
product
observ
patient
mix
connect
tissu
diseas
mctd
aeca
mctd
patient
may
activ
ec
upregul
eselectin
express
may
implic
pathogenesi
mctd
dcruz
et
al
describ
interest
associ
aeca
level
interstiti
lung
diseas
form
idiopath
inflammatori
myopathi
behcet
diseas
bd
report
preval
aeca
vari
wide
signific
associ
aeca
thrombosi
vascul
well
diseas
activ
bd
report
dinc
et
al
describ
low
preval
aeca
larg
seri
turkish
behcet
patient
without
signific
diver
healthi
control
new
techniqu
describ
lee
et
al
demonstr
first
time
aeca
igm
sera
patient
activ
bd
react
strongli
human
alphaenolas
protein
hdmec
aeca
frequent
detect
inflammatori
bowel
diseas
although
associ
activ
extens
coliti
seem
less
diseas
specif
autoantibodi
nevertheless
least
crohn
diseas
intestin
vascular
injuri
mediat
aeca
may
import
event
increas
evid
accumul
possibl
aeca
may
play
import
role
develop
progress
atherosclerot
lesion
farsi
et
al
describ
higher
rate
aeca
patient
unstabl
angina
evort
angina
aeca
posit
patient
also
posit
gpi
support
idea
gpi
major
aeca
target
antigen
thu
aeca
may
contribut
instabl
angina
associ
highrestenosi
rate
percutan
translumin
coronari
angioplasti
contrast
patient
without
coronari
atherosclerosi
confirm
angiographi
show
similar
aeca
level
target
antigen
aeca
acut
myocardi
infarct
may
endotheli
protein
c
receptor
report
mont
et
al
aeca
seem
involv
complex
pathogenesi
vascular
complic
diabet
although
other
suggest
associ
coexist
autoimmun
disord
put
cytotox
role
aeca
vs
ec
inner
ear
immunemedi
sudden
sensorineur
deaf
suggest
understand
relationship
autoimmun
diseas
infect
topic
interest
sever
decad
noteworthi
autoimmun
diseas
may
caus
trigger
infect
aeca
common
find
sever
infect
hcv
infect
autoantibodi
often
associ
mix
cryoglobulin
moreov
aeca
associ
acl
gpi
found
hiv
infect
aeca
antiepitheli
human
cell
antibodi
describ
sever
acut
respiratori
syndrom
sar
caus
infect
sarsassoci
coronaviru
patient
leprosi
natur
aeca
describ
healthi
subject
ronda
et
al
show
antibodi
interact
live
ec
avect
function
ligandreceptorlik
mechan
intern
natur
aeca
show
restrict
pattern
reactiv
compar
aeca
sle
patient
significantli
higher
level
igmaeca
found
normal
pregnanc
compar
healthi
nonpregn
control
pregnant
patient
sle
contrari
iggaeca
level
significantli
higher
serum
normal
pregnant
women
pregnant
sle
patient
serum
healthi
nonpregn
control
taken
togeth
find
support
physiolog
role
aeca
fetal
toler
normal
pregnant
women
well
pathogen
role
impair
reproduct
function
frequent
found
pregnant
sle
pathogen
abil
aeca
induc
endotheli
perturb
suggest
demonstr
complementdepend
cytotox
huvec
sera
patient
system
vascul
sle
particular
earli
report
demonstr
purifi
igm
much
lesser
extent
igg
patient
acut
convalesc
kd
abl
lyse
huvec
assess
releas
presenc
fresh
heat
inactiv
rabbit
serum
convers
simpl
incub
kd
igm
igg
fail
induc
direct
cytotox
addit
lytic
evect
observ
huvec
prestimul
either
ifng
monokin
suggest
exposur
neoantigen
endotheli
cell
necessari
bind
cytotox
antibodi
diver
preincub
time
requir
ifng
monokin
induc
bind
aeca
confer
cytotox
vitro
absorpt
experi
ifngor
monokinetr
huvec
suggest
diver
epitop
recogn
aeca
kd
follow
diver
huvec
stimul
similar
result
report
sle
moscato
et
al
show
sle
sera
purifi
igg
abl
fix
complement
vitro
lead
deposit
complement
compon
disrupt
endotheli
monolay
noteworthi
diver
earli
report
kd
sera
evect
observ
unstimul
huvec
basal
condit
suggest
cytotox
sle
aeca
may
recognis
diver
epitop
ec
requir
endotheli
activ
inflammatori
cytokin
complementdepend
cytotox
may
import
mechan
aeca
induc
endotheli
perturb
cell
damag
sle
system
vascul
abil
aeca
fix
complement
induc
complementdepend
cytotox
alway
confirm
autoimmun
diseas
particular
report
midand
late
fail
demonstr
abil
sera
patient
ssc
induc
complementdepend
cytotox
vitro
howev
shown
mechan
name
antibodydepend
cellular
cytotox
adcc
induct
ec
apoptosi
may
account
pathogen
potenti
aeca
ssc
autoimmun
diseas
includ
sle
vascul
abil
aeca
induc
ec
damag
via
adcclik
mechan
origin
demonstr
vitro
evalu
cytotox
evect
ssc
sera
huvec
monolay
fig
cytotox
activ
ec
either
venou
arteri
origin
assess
morpholog
chang
decreas
dna
h
thymidin
incorpor
reduc
fibronectin
product
increas
cr
releas
present
minor
sera
ssc
patient
rang
case
sera
also
abl
induc
cytotox
evect
dermal
fibroblast
observ
may
relev
understand
mechan
lead
skin
fibroblast
dysfunct
partial
explain
possibl
crossreact
endotheli
fibroblast
antigen
suggest
evid
absorpt
purifi
igg
ssc
sera
dermal
fibroblast
greatli
reduc
reactiv
toward
ec
although
diver
variou
report
exist
gener
convinc
whole
sera
purifi
igg
ssc
patient
abl
induc
cytotox
evect
ec
per
se
simpl
presenc
complement
cytotox
mechan
depend
presenc
evector
cell
cultur
medium
vitro
cocultur
experi
use
ec
ssc
sera
peripher
blood
mononuclear
cell
pbmc
demonstr
cytotox
depend
igg
aeca
reactiv
presenc
fc
receptor
evector
cell
mechan
highli
reminisc
adcc
pathogen
relev
observ
determin
endotheli
dysfunct
vivo
patient
ssc
still
known
discuss
previous
minor
ssc
sera
display
cytotox
activ
vitro
similarli
del
papa
et
al
show
igg
aeca
patient
wg
cytotox
ec
presenc
human
normal
pbmc
presenc
polymorphonuclear
leukocyt
adher
mononuclear
cell
nevertheless
well
known
aeca
repres
extrem
heterogen
famili
autoantibodi
varieti
target
antigen
also
heterogen
evect
togeth
cytotox
apoptosi
ec
mediat
bind
aeca
emerg
novel
mechan
aeca
may
exert
pathogen
role
autoimmun
condit
fig
particular
studi
focus
apoptot
evect
aeca
ssc
patient
sinc
sgonc
et
al
provid
evid
ec
deeper
dermi
patient
ssc
undergo
apoptosi
earli
stage
cours
diseas
process
area
character
earli
prefibrot
skin
lesion
result
also
confirm
avian
model
ssc
univers
california
davi
ucd
line
chicken
spontan
develop
sclerodermalik
diseas
character
perivascular
lymphocyt
infiltr
dermi
fibrosi
skin
intern
organ
presenc
serum
autoantibodi
antinuclear
antibodi
acl
antibodi
aeca
addit
case
endotheli
cell
apoptosi
associ
posit
stain
microvessel
ig
support
hypothesi
aeca
could
mediat
vascular
damag
sgonc
et
al
later
demonstr
aeca
subset
patient
ssc
abl
induc
apoptosi
hdmec
huvec
adcc
via
demonstr
vitro
inhibit
nkmediat
ec
apoptosi
use
block
antifasl
antibodi
convinc
evid
support
notion
aeca
abl
induc
overexpress
endotheli
adhes
molecul
eselectin
well
secret
proinflammatori
cytokin
ec
lead
upregul
leukocyt
adhes
ec
fig
suggest
import
role
aeca
contribut
vascular
damag
autoimmun
condit
sle
well
form
vascul
particular
aeca
patient
wg
induc
secret
ec
sever
evect
may
fig
pathogen
mechan
aeca
bind
aeca
ec
might
abl
induc
sever
evect
cytotox
mechan
resembl
adcc
mediat
complement
fixat
b
apoptosi
interact
endotheli
adher
induc
antigen
ie
gpi
hsp
indirectli
mediat
toll
annexin
ii
receptor
moreov
ec
apoptosi
may
induc
directli
interact
aeca
cd
fa
consequ
ec
apoptosi
constitut
antigen
apoptot
bleb
gpianion
phospholipid
complex
expos
immun
system
endotheli
surfac
moreov
endotheli
microparticl
may
releas
ec
c
proinflammatori
procoagul
evect
overexpress
induct
sever
adhes
molecul
cytokin
tissu
factor
respect
gpi
glycoproteini
tolllik
receptor
apl
antiphospholipid
antibodi
ps
phosphatidylserin
adcc
antibodydepend
cellular
cytotox
pbmc
peripher
blood
mononuclear
cell
tf
tissu
factor
pathogen
mechan
aeca
relat
autocrin
paracrin
action
gener
ec
respons
aeca
moreov
igm
aeca
may
stimul
releas
huvec
thu
increas
vascular
damag
suggest
preeclampsia
express
potenti
antigen
ec
suggest
treatment
cell
tumor
necrosi
factor
alpha
increas
igg
bind
sera
patient
activ
sle
heterogen
aeca
evect
observ
bordron
et
al
clearli
show
aeca
diver
patient
induc
activ
ec
aeca
other
induc
apoptosi
activ
ec
valid
yazici
et
al
describ
proinflammatori
evect
live
ec
due
monoclon
igg
aeca
gener
hybridoma
format
human
sle
b
cell
particular
mab
bound
ec
cell
membran
protein
induc
overexpress
eselectin
nfb
activ
similar
find
observ
mab
aeca
patient
ta
bound
activ
macrovascular
ec
microvascular
ec
mab
patient
wg
proinflammatori
phenotyp
ec
due
bind
aeca
may
also
depend
origin
ec
aynitypurifi
aeca
f
ab
patient
thrombot
thrombocytopen
purpura
ttp
bound
activ
microvascular
ec
larg
vessel
ec
contrari
urem
patient
undergo
hemodialysi
aeca
reactiv
huvec
microvascular
eahi
ec
line
observ
carvalho
et
al
first
report
aeca
ssc
patient
abl
function
avect
vitro
interact
ec
leukocyt
increas
adhes
myelomonocyt
cell
line
cultur
huvec
evect
reproduc
mediat
sera
well
purifi
igg
aeca
posit
ssc
patient
bind
ec
relat
de
novo
increas
express
selectin
adhes
molecul
ie
eselectin
huvec
vitro
system
leukocyteendotheli
cell
interact
depend
fc
engag
cell
sinc
fab
fragment
also
induc
leukocyt
adhes
similar
eycaci
compar
whole
igg
howev
suggest
kinet
leukocyt
adhes
adhes
molecul
express
evect
aeca
depend
direct
stimul
solubl
mediat
huvec
sinc
abil
induc
leukocyt
adhes
ec
maintain
use
iggdeplet
aecacondit
huvec
medium
inhibit
experi
use
cocktail
block
antibodi
suggest
evect
aeca
least
part
mediat
stimul
cytokin
product
particular
huvec
vitro
although
exhaust
proof
abil
aeca
ssc
patient
directli
induc
cytokin
product
huvec
miss
studi
aeca
rheumat
condit
ie
wg
report
previous
shown
upregul
cytokin
express
ec
vitro
role
apl
aeca
pathogenesi
ap
well
investig
sinc
first
descript
aeca
evid
antibodi
direct
neg
charg
phospholipid
explain
part
aeca
reactiv
fact
absorpt
cardiolipin
liposom
partial
inhibit
aeca
reactiv
thu
like
aeca
direct
apl
may
involv
thrombot
diathesi
via
one
mechan
first
antibodi
may
activ
ec
apoptot
nonapoptot
mechan
fig
c
second
autoantibodi
may
induc
signific
increas
tissu
factor
tf
transcript
express
ec
well
monocyt
incub
ec
igg
patient
posit
apl
increas
express
eselectin
previous
report
aeca
studi
shown
upregul
adhes
molecul
ec
apl
correl
increas
adhes
leukocyt
ec
mous
microcircul
enhanc
thrombosi
vivo
pretreat
ec
fluvastatin
increas
express
ec
activ
well
tf
express
pretreat
aspirin
decreas
cell
surfac
ec
contrari
previou
studi
show
fluvastatin
abl
inhibit
express
tf
express
ec
induc
apl
patient
ap
well
aynitypurifi
polyclon
iggapl
igm
human
monoclon
gpi
antibodi
moreov
fluvastatin
mous
model
significantli
diminish
aplmedi
thrombosi
ec
activ
vivo
novel
pathway
ec
activ
induc
gpi
antibodi
may
due
crosslink
cluster
annexin
endotheli
surfac
dieud
et
al
show
aeca
sle
patient
ap
bind
surfac
ec
share
reactiv
ec
surfac
polypeptid
identifi
human
moreov
incub
ec
purifi
antibodi
induc
apoptosi
demonstr
exposur
phosphatidylserin
plasma
membran
although
aeca
reactiv
exclus
sle
patient
intrigu
associ
observ
antibodi
lac
may
repres
first
pathogen
hit
induct
aeca
endotheli
perturb
follow
second
hit
repres
apl
antibodi
bind
ec
line
result
purifi
patient
coronaryarteri
diseas
may
caus
apoptosi
nonstress
ec
consid
primari
event
pathogenesi
atherosclerosi
accord
hypothesi
chen
et
al
show
apl
bind
ec
occur
activ
cell
worda
et
al
report
evid
vivo
bind
aeca
microvascular
endothelium
associ
signific
increas
ec
apoptosi
line
evid
aeca
might
induc
endotheli
perturb
releas
endotheli
microparticl
describ
sera
patient
ap
taken
togeth
find
support
idea
aeca
may
pathogen
may
abl
induc
apl
product
evect
apl
ec
may
mediat
overexpress
tf
line
hypothesi
vegaostertag
et
al
show
treatment
igg
patient
apl
induc
signific
increas
tf
transcript
express
activ
huvec
mediat
phosphoryl
mapk
activ
nfb
aeca
repres
heterogen
famili
autoantibodi
direct
sever
antigen
includ
partial
overlap
specif
sever
find
suggest
gpi
relev
antigen
ap
also
show
aeca
reactiv
gpi
plasma
protein
abl
bind
anion
phospholipid
apolipoprotein
repres
cofactor
requir
gener
antigen
epitop
recogn
apl
pure
gpi
antibodi
also
detect
bind
gpi
sever
cell
apoptot
thymocyt
trophoblast
cell
macrophag
platelet
ec
previous
report
particular
immunoreact
gpi
larg
investig
ec
whether
reactiv
due
plasma
adhes
direct
intracellular
synthesi
glycoprotein
ec
still
debat
disappear
gpi
immunoreact
describ
follow
extens
wash
huvec
cultur
serumfre
medium
interestingli
phenomenon
found
use
primari
human
ec
cultur
skin
brain
microcircul
suggest
capabl
cell
type
synthes
gpi
regard
group
clearli
demonstr
gpi
mrna
express
ec
cultur
absenc
presenc
gpi
cultur
medium
conceiv
ec
constitut
express
gpi
mrna
sinc
cultur
absenc
gpi
sever
day
influenc
gpi
mrna
synthesi
ec
find
also
support
observ
ec
gpi
locat
accumul
late
endosom
result
observ
astrocyt
neuron
human
monocyt
evid
gpi
also
express
vivo
trophoblast
vessel
term
placenta
well
circul
monocyt
immunoreact
gpi
express
sever
cell
involv
photogen
scenario
ap
may
due
part
direct
gpi
synthesi
hand
possibl
specul
gpi
synthesi
may
increas
vitro
stress
condit
serum
deplet
cultur
medium
fact
import
point
plasma
protein
gpi
may
also
absorb
cell
membran
directli
endotheli
receptor
line
hypothesi
suggest
gpi
might
interact
anion
ec
membran
structur
heparan
sulfat
hs
annexin
apolipoprotein
e
receptor
review
ref
although
previou
studi
show
minim
influenc
gpi
aeca
reactiv
date
well
accept
gpi
ec
may
target
aeca
raschi
et
al
clearli
demonstr
human
monoclon
igm
antibodi
gpi
well
aynitypurifi
polyclon
gpi
induc
phosphoryl
receptoractiv
kinas
irak
suggest
gpi
might
interact
homolog
microbi
structur
aeca
repres
heterogen
famili
autoantibodi
direct
sever
antigen
includ
partial
overlap
specif
despit
fact
studi
shown
higher
preval
aeca
autoimmun
diseas
clinic
relev
autoantibodi
still
matter
debat
need
confirm
longitudin
studi
larg
number
patient
nevertheless
mani
evid
pathogen
role
aeca
sle
ap
ssc
vascul
moreov
futur
evalu
aeca
use
substrat
ec
macroand
microvasculatur
may
import
assess
precis
aeca
reactiv
variou
form
autoimmun
diseas
reason
believ
precis
definit
aeca
role
autoimmun
diseas
includ
research
agenda
